The immune system plays a central role not only in fighting infections, but
also in many other diseases and medical conditions including cancer.
The study of the immune system has lead to significant findings in many fields of medicine and biology and resulted in the discovery of novel and unique substances and reagents that are now widely used for diagnosis, evaluation and therapy of different
malignant diseases.
The development of prophylactic and therapeutic vaccines, as well as innovative
combinatorial immunotherapeutic approaches for patients with cancer has substantially decreased mortality and morbidity and improved the life style, life expectancy, and well being of the millions of patients with
malignant diseases.
Thus, the field of Cancer Immunotherapy and Immunomonitoring (CITIM) is of continuously escalating significance, as well as scientifically, economically and socially important.
CITIM Conference allows scientists, clinicians, medical practitioners and specialists, students, R&D experts and patients to meet together and discuss the latest therapeutic, preventive and diagnostic developments in the field.
|
